Claim OwnershipPharma Sessions
Subscribed: 2Played: 2
Subscribe
© 2024 Pharma Sessions
Description
Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
22 Episodes
Reverse
Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product LaunchesThis episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position. Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies. The discussion transla...
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care.They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies. Lars shares his transition from academia to the pharmaceutical industry, the thrill of t...
This episode is sponsored by Acceleration Point. Pharma Sessions is hosted by Jonathan KaskeyIn this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs. Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements. Scott encourages experimentation with secure, customized AI tools to improve output. He outlines a case study where AI improved ...
Life is different at a biotech. But is that a good thing?Like so much in life, the answer is, "it depends."On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies. He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team. Orlando also ...
The Science of Sleep: Exploring its Role in Performance and Well-being for Medical AffairsIn this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health. They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function. On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced product...
In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US. Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches.&nbs...
In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs. Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen.Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness. Megan emphasizes the significance of maintaining a positive relationship with compliance off...
In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc.With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you'll learn:1. The importance of patient-centered outcomes researc...
Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry.Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training.Top 5 learnings from the episode:The critical need for data sharing in ...
In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals. From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out. Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals. Tune in now to master the art of time management and increase your prod...
We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry.Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo Review, Scientific Training & Development at Alkermes.Tim has been in the medical information role for 15 years and shared valuable insights on the importance of receiving and responding to inquiries, reviewing content, and researching answers in medical in...
This episode is the second in Pharma Sessions' series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community oriented perspective.Renarda Jones is a clinical trial professional with over 20 years’ experience in clinical research., mainly in Cancer and Alzheimer’s disease research.Starting as a research assistant, working her way up to study coordinator and clin...
In Today’s episode Tom Caravela and I explore the question–what does a perfect MSL organization to support a product launch look like?I’ve knonw Tom for years, and asked him to share his unique perspective on field medical organizations.In addition to being a certified speaker, trainer and coach as well as a podcaster, Tom is the founder of an Executive Search Firm called The Carolan Group. They’re known for their niche expertise for specializing in the recruitment and placement of highly sci...
Steve Royle is an innovative pharmaceutical professional with experience in both the commercial and medical affairs sides of the industry. After starting in sales and marketing, Steve moved to the agency side of global medical communications and medical education. He went on to found Swipe Health and Rumi. Recently, Steve has used his expertise to create mymedicalafairs.com, a Netflix-style database of medical affairs events and topics. Through mymedicalaffairs.com, we crowdsourced...
Chris Caudle is a LinkedIn specialist for execs working in the healthcare and life sciences sectors. He helps clients to develop their personal brand, increase their visibility, leadership and reach bigger audiences using LinkedIn as their launchpad.In this episode Chris talks about how to use social media, specifically LinkedIn. He discusses the benefits of having a strong online brand and how to make it stand out.Chris and Jon talk give examples about using social not only for personal bran...
Amber Spierer is the VP of Patient Affairs at EQRx, formally head of US Patient Engagement at Novartis.We talk about: Defining the patient journeyWhy understanding this journey is important strategicallyThe difference between viewing someone as a patient and as a personCurrent patient expectations around working with pharmaTacticsThe views expressed here are mine and Amber’s, and don’t reflect those of our employers.Pharma Sessions is hosted by Jonathan KaskeyFollow along on Linked...
I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.We talk about: Transitioning from clinical practice to med affairsChanges in how other groups in pharma see med affairsThe differences between access and adoption (and how to impact both)Advances in patient engagement and much moreA quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.At one point I reference the MAPS, Future of Medical Affairs report. You can ...
Danie du Plessis is the EVP of Medical Affairs for Kyowa Kirin, a board member at the Medical Affairs Professional Society, and was previously the SVP of Global Medical Affairs for GSK. We talk about: Why Danie switched from primary care to working with pharmaIf a business background is important in med affairs leadershipLeading big organizations vs small organizationsHow important an understanding of the patient journey is to everything med affairsPharma Sessions is hosted by Jonat...
Camille Pope is the Chief Medical Lead at Acclinate, helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.She'd previously worked for several large pharmaceutical companies in both field medical and medical affairs leadership roles.We discuss the importance of diversity in clinical trials, the new FDA guidance, the impacts that a lack of trial diversity can have when presenting information to patients and providers,...
Comments
Download from Google Play
Download from App Store
United States